MDC ASX Chart
Snapshot
Medlab Clinical Limited (MDC) is an Australian biotechnology company that specialises in the application of NanoCelle drug delivery technology to existing and new pharmaceuticals - with the aim of empowering patients with chronic diseases and mental health conditions and enhancing their lives.
Share Price Activity (ASX)
| Last (Price) | |
| Change | 0.00 (0.00) |
| Bid / Ask | - |
| Volume | |
| Volume (4w avg) | |
| Turnover | |
| Open | |
| Day Range | - |
| VWAP | |
| Prev Close | |
| Last Trade |
Performance
| 1 Week | |
| 1 Month | |
| 2026 YTD | |
| 1 Year | |
| vs Sector (1yr) | +46.63% |
| vs ASX 200 (1yr) | -1.42% |
Announcements
Corporate Overview
Corporate Details
| Head Office | |
| Website | - |
| Registry | Automic Group |
| Auditor | MNSA Pty Ltd |
| Date Listed | 14 Jul 2015 |
Upcoming Calendar (Forecasted)
No calendar entries available.
Former Company Names
- Medlab Clinical Ltd has no former company names.
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
MDC directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of MDC directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
| Name | Last Notice | Total Shares | Shares Held (%) |
|---|---|---|---|
| Sean Michael Hall | 25/10/2024 | 389,041 | 17.04 |
| Farjoy Pty Ltd | 25/10/2024 | 205,663 | 9.01 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
| Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
Historical Data
| Year | Closing Price | Last Trade |
|---|---|---|
| 2025 | $6.60 | 28 February |
| 2024 | $6.60 | 28 June |
| 2023 | $6.60 | 30 June |
| 2022 | $0.048 | 30 June |
| 2021 | $0.145 | 30 June |
| 2020 | $0.15 | 30 June |
| 2019 | $0.35 | 28 June |
| 2018 | $0.55 | 29 June |
| 2017 | $0.855 | 30 June |
| 2016 | $0.46 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.